Feb. 27, 2004 — Scheduled maintenance with infliximab reduced hospitalizations and improved healing compared with episodic dosing for patients with Crohn's disease, according to the results of a ...
Intensified or accelerated dosing regimens with infliximab (Remicade) did not improve outcomes compared with the standard regimen in patients with steroid-refractory acute severe ulcerative colitis ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Biosimilar infliximab use is significantly more common among new users vs. those who started with ...
One-fourth of patients who switched to an infliximab biosimilar retransitioned back to the originator, but they were more likely to subsequently discontinue treatment due to an unwanted response after ...
Please provide your email address to receive an email when new articles are posted on . PHOENIX — In this video, Medora Rodrigues, MD, a hospitalist at The Ohio State University Wexner Medical Center, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results